Table of Contents
Editorial
| Mike Kew: A physician-scientist, teacher and role model extraordinaire with an enduring influence on excellence and mentorship in medicine | |
| N Ntusi | 2-3 |
Introduction
| Introduction | |
| J E J Krige | 3 |
| Michael Charles Kew: A chronicle of his career | |
| J H Hoofnagle | 4-5 |
| Professor Mike Kew and the Royal Free Hospital | |
| M Pinzani | 6 |
Tributes
| Tributes from senior academics from the University of the Witwatersrand | |
| T H Bothwell | 7-9 |
| Tributes from the Gastroenterology Foundation of South Africa | |
| C Kassianides | 10-12 |
Research
| Towards the elimination of hepatitis B and hepatocellular carcinoma | |
| C W Spearman | 13-16 |
| Molecular characteristics and clinical relevance of African genotypes and subgenotypes of hepatitis B virus | |
| A Kramvis | 17-21 |
| Current and future directions for the management of hepatitis B | |
| G Dusheiko | 22-30 |
| The global elimination of hepatitis C? | |
| M W Sonderup | 31-34 |
| Hepatocellular carcinoma: Epidemiology, pathogenesis and surveillance – implications for sub-Saharan Africa | |
| K Zakharia, C A Luther, H Alsabbak, L R Roberts | 35-40 |
| Molecular and cellular oncogenic mechanisms in hepatocellular carcinoma | |
| M Setshedi, M Andersson, M M Kgatle, L Roberts | 41-46 |
| Prevention of hepatocellular carcinoma with antiviral therapy | |
| AM Di Bisceglie | 47-50 |
| Hepatocellular carcinoma in sub-Saharan Africa – the way forward | |
| E Jonas | 51 |
.gif)


_web.gif)